Ryberg D - Search Results

1

GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients.

Hou SM, Ryberg D, Fält S, Deverill A, Tefre T, Børresen AL, Haugen A, Lambert B. Hou SM, et al. Among authors: ryberg d. Carcinogenesis. 2000 Jan;21(1):49-54. doi: 10.1093/carcin/21.1.49. Carcinogenesis. 2000. PMID: 10607733

2

Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk.

Benhamou S, Lee WJ, Alexandrie AK, Boffetta P, Bouchardy C, Butkiewicz D, Brockmöller J, Clapper ML, Daly A, Dolzan V, Ford J, Gaspari L, Haugen A, Hirvonen A, Husgafvel-Pursiainen K, Ingelman-Sundberg M, Kalina I, Kihara M, Kremers P, Le Marchand L, London SJ, Nazar-Stewart V, Onon-Kihara M, Rannug A, Romkes M, Ryberg D, Seidegard J, Shields P, Strange RC, Stücker I, To-Figueras J, Brennan P, Taioli E. Benhamou S, et al. Among authors: ryberg d. Carcinogenesis. 2002 Aug;23(8):1343-50. doi: 10.1093/carcin/23.8.1343. Carcinogenesis. 2002. PMID: 12151353

3

A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.

Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland LB, Canzian F, Haugen A. Zienolddiny S, et al. Among authors: ryberg d. Carcinogenesis. 2008 Jun;29(6):1164-9. doi: 10.1093/carcin/bgn020. Epub 2008 Feb 6. Carcinogenesis. 2008. PMID: 18258609

4

Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk.

Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Ogreid D, Ulvik A, Vu P, Haugen A. Ryberg D, et al. Carcinogenesis. 1997 Jul;18(7):1285-9. doi: 10.1093/carcin/18.7.1285. Carcinogenesis. 1997. PMID: 9230269

5

Induction of microsatellite mutations by oxidative agents in human lung cancer cell lines.

Zienolddiny S, Ryberg D, Haugen A. Zienolddiny S, et al. Among authors: ryberg d. Carcinogenesis. 2000 Aug;21(8):1521-6. Carcinogenesis. 2000. PMID: 10910953

6

Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.

Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F, Haugen A. Zienolddiny S, et al. Among authors: ryberg d. Carcinogenesis. 2006 Mar;27(3):560-7. doi: 10.1093/carcin/bgi232. Epub 2005 Sep 29. Carcinogenesis. 2006. PMID: 16195237

7

Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population.

Tefre T, Ryberg D, Haugen A, Nebert DW, Skaug V, Brøgger A, Børresen AL. Tefre T, et al. Among authors: ryberg d. Pharmacogenetics. 1991 Oct;1(1):20-5. doi: 10.1097/00008571-199110000-00004. Pharmacogenetics. 1991. PMID: 1726950

8

Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients.

Ryberg D, Hewer A, Phillips DH, Haugen A. Ryberg D, et al. Cancer Res. 1994 Nov 15;54(22):5801-3. Cancer Res. 1994. PMID: 7954403

9

p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer.

Ryberg D, Kure E, Lystad S, Skaug V, Stangeland L, Mercy I, Børresen AL, Haugen A. Ryberg D, et al. Cancer Res. 1994 Mar 15;54(6):1551-5. Cancer Res. 1994. PMID: 8137262

10

p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels.

Kure EH, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, Haugen A. Kure EH, et al. Among authors: ryberg d. Carcinogenesis. 1996 Oct;17(10):2201-5. doi: 10.1093/carcin/17.10.2201. Carcinogenesis. 1996. PMID: 8895489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page